BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ballout F, Habli Z, Rahal ON, Fatfat M, Gali-Muhtasib H. Thymoquinone-based nanotechnology for cancer therapy: promises and challenges. Drug Discov Today 2018;23:1089-98. [PMID: 29374534 DOI: 10.1016/j.drudis.2018.01.043] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 9.5] [Reference Citation Analysis]
Number Citing Articles
1 Shariare MH, Khan MA, Al-Masum A, Khan JH, Uddin J, Kazi M. Development of Stable Liposomal Drug Delivery System of Thymoquinone and Its In Vitro Anticancer Studies Using Breast Cancer and Cervical Cancer Cell Lines. Molecules 2022;27:6744. [PMID: 36235288 DOI: 10.3390/molecules27196744] [Reference Citation Analysis]
2 Imam SS, Gilani SJ, Bin Jumah MN, Rizwanullah M, Zafar A, Ahmed MM, Alshehri S. Harnessing Lipid Polymer Hybrid Nanoparticles for Enhanced Oral Bioavailability of Thymoquinone: In Vitro and In Vivo Assessments. Polymers 2022;14:3705. [DOI: 10.3390/polym14183705] [Reference Citation Analysis]
3 Butnariu M, Quispe C, Herrera-Bravo J, Helon P, Kukula-Koch W, López V, Les F, Vergara CV, Alarcón-Zapata P, Alarcón-Zapata B, Martorell M, Pentea M, Dragunescu AA, Samfira I, Yessimsiitova Z, Daştan SD, Castillo CMS, Roberts TH, Sharifi-Rad J, Koch W, Cho WC. The effects of thymoquinone on pancreatic cancer: Evidence from preclinical studies. Biomed Pharmacother 2022;153:113364. [PMID: 35810693 DOI: 10.1016/j.biopha.2022.113364] [Reference Citation Analysis]
4 David Q, de la Luz ZM, Gerardo L, Mendoza‐muñoz N. Liposomal Nanotechnology in Nutraceuticals. Handbook of Nutraceuticals and Natural Products 2022. [DOI: 10.1002/9781119746843.ch3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sofyan F, Munir D, Putra IB, Wardani RS, Hadi RS, Zahara D, Sembiring RJ, Rambe AYM, Ashar T. Effect of Thymoquinone and Transforming Growth Factor-β1 on the Cell Viability of Nasal Polyp-Derived Fibroblast. Open Access Maced J Med Sci 2022;10:1392-1398. [DOI: 10.3889/oamjms.2022.9516] [Reference Citation Analysis]
6 Homayoonfal M, Asemi Z, Yousefi B. Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis. Cell Mol Biol Lett 2022;27:21. [PMID: 35236304 DOI: 10.1186/s11658-022-00320-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 Phua CYH, Teoh ZL, Goh BH, Yap WH, Tang YQ. Triangulating the pharmacological properties of thymoquinone in regulating reactive oxygen species, inflammation, and cancer: Therapeutic applications and mechanistic pathways. Life Sci 2021;287:120120. [PMID: 34762903 DOI: 10.1016/j.lfs.2021.120120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Lodovichi J, Landucci E, Pitto L, Gisone I, D'Ambrosio M, Luceri C, Salvatici MC, Bergonzi MC. Evaluation of the increase of the thymoquinone permeability formulated in polymeric micelles: In vitro test and in vivo toxicity assessment in Zebrafish embryos. Eur J Pharm Sci 2021;169:106090. [PMID: 34864170 DOI: 10.1016/j.ejps.2021.106090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Gnanasekaran P, Roy A, Sirpu Natesh N, Raman V, Ganapathy P, Arumugam MK. Removal of microbial pathogens and anticancer activity of synthesized nano-thymoquinone from Nigella sativa seeds. Environmental Technology & Innovation 2021;24:102068. [DOI: 10.1016/j.eti.2021.102068] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Alaaeldin E, Mostafa M, Mansour HF, Soliman GM. Spanlastics as an efficient delivery system for the enhancement of thymoquinone anticancer efficacy: Fabrication and cytotoxic studies against breast cancer cell lines. Journal of Drug Delivery Science and Technology 2021;65:102725. [DOI: 10.1016/j.jddst.2021.102725] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Noor NS, Kaus NHM, Szewczuk MR, Hamid SBS. Formulation, Characterization and Cytotoxicity Effects of Novel Thymoquinone-PLGA-PF68 Nanoparticles. Int J Mol Sci 2021;22:9420. [PMID: 34502328 DOI: 10.3390/ijms22179420] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Rahat I, Rizwanullah M, Gilani SJ, Bin-jummah MN, Imam SS, Kala C, Asif M, Alshehri S, Sharma SK. Thymoquinone loaded chitosan - Solid lipid nanoparticles: Formulation optimization to oral bioavailability study. Journal of Drug Delivery Science and Technology 2021;64:102565. [DOI: 10.1016/j.jddst.2021.102565] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
13 Malik S, Singh A, Negi P, Kapoor VK. Thymoquinone: A small molecule from nature with high therapeutic potential. Drug Discov Today 2021:S1359-6446(21)00320-2. [PMID: 34303824 DOI: 10.1016/j.drudis.2021.07.013] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
14 Berehab M, Rouas R, Akl H, Duvillier H, Journe F, Fayyad-Kazan H, Ghanem G, Bron D, Lewalle P, Merimi M. Apoptotic and Non-Apoptotic Modalities of Thymoquinone-Induced Lymphoma Cell Death: Highlight of the Role of Cytosolic Calcium and Necroptosis. Cancers (Basel) 2021;13:3579. [PMID: 34298792 DOI: 10.3390/cancers13143579] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Rahat I, Imam SS, Rizwanullah M, Alshehri S, Asif M, Kala C, Taleuzzaman M. Thymoquinone-entrapped chitosan-modified nanoparticles: formulation optimization to preclinical bioavailability assessments. Drug Deliv 2021;28:973-84. [PMID: 34036860 DOI: 10.1080/10717544.2021.1927245] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
16 Pashanova KI, Goryunova PE, Sologubov SS, Markin AV, Smirnova NN, Piskunov AV. Standard Thermochemical Characteristics of Combustion and Formation of Bulky Benzoquinone-Type Derivatives at T = 298.15 K. J Chem Eng Data 2021;66:1970-1976. [DOI: 10.1021/acs.jced.0c01042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Radwan MF, El-Moselhy MA, Alarif WM, Orif M, Alruwaili NK, Alhakamy NA. Optimization of Thymoquinone-Loaded Self-Nanoemulsion for Management of Indomethacin-Induced Ulcer. Dose Response 2021;19:15593258211013655. [PMID: 33994890 DOI: 10.1177/15593258211013655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Almajali B, Al-Jamal HAN, Taib WRW, Ismail I, Johan MF, Doolaanea AA, Ibrahim WN. Thymoquinone, as a Novel Therapeutic Candidate of Cancers. Pharmaceuticals (Basel) 2021;14:369. [PMID: 33923474 DOI: 10.3390/ph14040369] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
19 Rachamalla HK, Bhattacharya S, Ahmad A, Sridharan K, Madamsetty VS, Mondal SK, Wang E, Dutta SK, Jan BL, Jinka S, Chandra Sekhar Jaggarapu MM, Yakati V, Mukhopadhyay D, Alkharfy KM, Banerjee R. Enriched pharmacokinetic behavior and antitumor efficacy of thymoquinone by liposomal delivery. Nanomedicine (Lond) 2021;16:641-56. [PMID: 33769068 DOI: 10.2217/nnm-2020-0470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 AbouAitah K, Lojkowski W. Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy. Pharmaceutics 2021;13:143. [PMID: 33499150 DOI: 10.3390/pharmaceutics13020143] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
21 Edris AE. Thymoquinone: Chemistry and Functionality. Black cumin (Nigella sativa) seeds: Chemistry, Technology, Functionality, and Applications 2021. [DOI: 10.1007/978-3-030-48798-0_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Alshehri S, Imam SS, Rizwanullah M, Fakhri KU, Rizvi MMA, Mahdi W, Kazi M. Effect of Chitosan Coating on PLGA Nanoparticles for Oral Delivery of Thymoquinone: In Vitro, Ex Vivo, and Cancer Cell Line Assessments. Coatings 2021;11:6. [DOI: 10.3390/coatings11010006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
23 Mehanna MM, Sarieddine R, Alwattar JK, Chouaib R, Gali-Muhtasib H. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization. Int J Nanomedicine 2020;15:9557-70. [PMID: 33293807 DOI: 10.2147/IJN.S263797] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
24 Bergonzi MC, Vasarri M, Marroncini G, Barletta E, Degl'Innocenti D. Thymoquinone-Loaded Soluplus®-Solutol® HS15 Mixed Micelles: Preparation, In Vitro Characterization, and Effect on the SH-SY5Y Cell Migration. Molecules 2020;25:E4707. [PMID: 33066549 DOI: 10.3390/molecules25204707] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
25 Sunoqrot S, Alfaraj M, Hammad AM, Kasabri V, Shalabi D, Deeb AA, Hasan Ibrahim L, Shnewer K, Yousef I. Development of a Thymoquinone Polymeric Anticancer Nanomedicine through Optimization of Polymer Molecular Weight and Nanoparticle Architecture. Pharmaceutics 2020;12:E811. [PMID: 32867015 DOI: 10.3390/pharmaceutics12090811] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
26 Ballout F, Monzer A, Fatfat M, Ouweini HE, Jaffa MA, Abdel-Samad R, Darwiche N, Abou-Kheir W, Gali-Muhtasib H. Thymoquinone induces apoptosis and DNA damage in 5-Fluorouracil-resistant colorectal cancer stem/progenitor cells. Oncotarget. 2020;11:2959-2972. [PMID: 32821342 DOI: 10.18632/oncotarget.27426] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
27 Rashid M, Sanjarin F, Sabouni F. Thymoquinone Effects on Cell Viability, Apoptosis and VEGF-A Gene Expression Level in AGS(CRL-1739) Cell Line. Anticancer Agents Med Chem 2019;19:820-6. [PMID: 30727919 DOI: 10.2174/1871520619666190206163504] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
28 Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto TJA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Nanocarriers: more than tour de force for thymoquinone. Expert Opin Drug Deliv 2020;17:479-94. [PMID: 32077770 DOI: 10.1080/17425247.2020.1730808] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
29 Pushpa Sweety J, Sowparani S, Mahalakshmi P, Selvasudha N, Yamini D, Geetha K, Ruckmani K. Fabrication of stimuli gated nanoformulation for site-specific delivery of thymoquinone for colon cancer treatment – Insight into thymoquinone’s improved physicochemical properties. Journal of Drug Delivery Science and Technology 2020;55:101334. [DOI: 10.1016/j.jddst.2019.101334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
30 Rathore C, Upadhyay N, Kaundal R, Dwivedi RP, Rahatekar S, John A, Dua K, Tambuwala MM, Jain S, Chaudari D, Negi P. Enhanced oral bioavailability and hepatoprotective activity of thymoquinone in the form of phospholipidic nano-constructs. Expert Opin Drug Deliv 2020;17:237-53. [PMID: 32003249 DOI: 10.1080/17425247.2020.1716728] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
31 Pham DC, Shibu MA, Mahalakshmi B, Velmurugan BK. Effects of phytochemicals on cellular signaling: reviewing their recent usage approaches. Crit Rev Food Sci Nutr 2020;60:3522-46. [PMID: 31822111 DOI: 10.1080/10408398.2019.1699014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
32 Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta Rev Cancer. 2019;1873:188314. [PMID: 31682895 DOI: 10.1016/j.bbcan.2019.188314] [Cited by in Crossref: 262] [Cited by in F6Publishing: 225] [Article Influence: 87.3] [Reference Citation Analysis]
33 Zhu N, Xiang Y, Zhao X, Cai C, Chen H, Jiang W, Wang Y, Zeng C. Thymoquinone suppresses platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferation, migration and neointimal formation. J Cell Mol Med 2019;23:8482-92. [PMID: 31638340 DOI: 10.1111/jcmm.14738] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
34 Rathore C, Upadhyay NK, Sharma A, Lal UR, Raza K, Negi P. Phospholipid nanoformulation of thymoquinone with enhanced bioavailability: Development, characterization and anti-inflammatory activity. Journal of Drug Delivery Science and Technology 2019;52:316-24. [DOI: 10.1016/j.jddst.2019.04.041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
35 Basu P, Vadlapatla R, Kumar P, Gray JP. Misc. medical devices and technologies. Side Effects of Drugs Annual 2019. [DOI: 10.1016/bs.seda.2019.08.008] [Reference Citation Analysis]
36 Mohammadabadi M, Mozafari M. Enhanced efficacy and bioavailability of thymoquinone using nanoliposomal dosage form. Journal of Drug Delivery Science and Technology 2018;47:445-53. [DOI: 10.1016/j.jddst.2018.08.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
37 El-Far AH, Al Jaouni SK, Li W, Mousa SA. Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases. Nutrients 2018;10:E1369. [PMID: 30257423 DOI: 10.3390/nu10101369] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
38 Agrahari V, Agrahari V. Novel nanotherapeutic strategies: fabrication approaches, application and clinical challenges. Drug Discovery Today 2018;23:931-933. [DOI: 10.1016/j.drudis.2018.04.008] [Reference Citation Analysis]